George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
A little morsel to chew on, perhaps.
It seems, to me, not unreasonable to assume that as Abingdon are busying themselves, completing pre-production batches (as Marik outlines), that Calibre must be utilising most, if not all the capacity from GAD (to require the green lighting of additional capacity from Abingdon).
ergo - the possibility seems high of at least 1M tests (at least) being demanded by the market right now, with clear?? Indications of additional unmet demand waiting to be fulfilled.
Prompted by Marik's exchange with Lveandlearn; I think weight of evidence is erring toward Marik's point - that we are likely at capacity with GAD, hence the need to bring Abingdon on-stream ASAP - Calibre have additional demand and can't currently meet it.
Well yes, let's hope so! We are making progress. Hoorah!
Indeed, it did seem rather pre-prepared and scripted from CR.
Brought some buyers in.
Pedro:
Yes , Ajay certainly made sure he got his business points across; did he take a breath.
Gidget:
Wouldn't it have raised an eyebrow had he said "yes, because of the collaboration with Deepverge, their AI platform using real-time detection.... blah, blah".
Clearly, asking too much.
Mmm, agreed Frix, seemed a little disappointing (on scope, content) given, as you said, the rushed nature of the whole debate; I hoped, as I'm sure many did, that an opportunity to touch on collaborations between MW and some of these 'Players' might have been forthcoming. Still, much needed exposure.
And actually, he contradicts himself at the end, says 200 sign up's per day at 30%.
Make of that what you will, maybe a slip, bah, don't we should worry too much.
No, don't have that info
I used £85 actually, times 70 per day
For a start, it is very good, I think.
No mate, he says "at a conversion rate of 35%
So, as a baseline - just over £2000,000 - £2,171,750 to be exact. Just to start!
The bulletin board is a forum for useful, productive discussion. It is not, not a vehicle for a few vested interests to peddle a daily and weekly narrative to drive down share prices.
Don't you get it? It isn't a platform to trot out negative threads and posts - Ad nauseam.
And Paul?con?Muggins - beyond pathetic. Always thought you may be associated with Muggins and sons - you rubber-stamped it.
This, preposterous:
“Muggins is not a de-ramper, he is concerned that the share price is falling and made comment about it. It seems likely that the price will fall into the teens so that GB and his buddies can benefit from a merger with MSYS. It will happen. Perhaps the best outcome would be a buy out from CR with 50% uplift”.
NO ONE drives their own share price into the ground with a months long stream of abuse, no one. You're either an associated facilitator or fantasist.
Desmond - I wholeheartedly agree with you.
"All the crybaby bedwetters moaning about a drop from 32p to 22p need to relax. Rome was not built in a day."
A truism if ever there was one.
A very fair observation Frix, it is a little odd. Email GB.
Whoops - slip from me - contributors
Looking forward to updates and any feedback from contributors.
Looking forward to updates and any feedback from contributers.
Would be great if you could have several pieces of pertinent info pinned; might act to some limited degree, as an antidote to the teams of manipulators - great idea. Can't see LSE going for it though, I have said in the past that I feel they are knowing facilitators of manipulation; nothing I've seen recently causes me to revise that view.
Hopefully, as the increased capacity comes on stream and per unit prices come down, the headline costs of a multi unit installation will become a much more appealing proposition to those towns and cities that may wish to implement a comprehensive solution; as apposed to having the trainee zooming around in their van, manually sampling!
"5 new laboratories were introduced earlier this year, so @Labskin
could expand its services to include polymerase chain reaction (PCR) and gene sequencing"
So not 2, as alluded to earlier in the year, but 5?? Baffled!
The guy needs to tighten up, Sir Alex Ferguson hairdryer required. Sloppy, disappointing.
Thanks for the great post, Trill. Changing the narrative.
An area of the business that has enjoyed significant growth and investment. Lots of transformative change in progress; despite what the naysayers might imply with their selective facts.
Cammy, with due respect.
You make 3 unreasonable suppositions:
"Staying in the low twenties till next year"
You don't this, how could you; any news of significant progress will have a material effect on the share price.
"which means a definite raise next year"
Well, no, because you can't know what the cash + loan position of the company will be next year; unless you can demonstrate a history of prescience.
"a raise in the low twenties means we’re in ****street for a long time"
And.... no, without that prescient gift, you're as hamstrung as the rest of us, presupposing that (a) we will be in the 20's and (b) that we will need to raise more money.
Baseless conjecture, and for why? I, myself, have made no price predictions as it seems a folly, particularly given the antics that go on here, so why do you feel the need? Your post says: Danger, Danger - cash raise ahead; stagnant share price ahead.
I do not understand your thinking, it makes no sense to me.